Global IV Tubing Sets and Accessories Market Size, Share & Forecast 2026–2033

The global IV tubing sets and accessories market Segments Covered by Product Type (Primary IV Tubing Sets, Secondary IV Tubing Sets, Extension IV Tubing Sets, IV Tubing Accessories, Others) by Application (Hydration, Blood Transfusions, Medication Delivery, Nutritional Support) by End-User (Hospitals, Clinics, Ambulatory Surgery Centers, Others) by Regions Covered (North America, Europe, Asia-Pacific, South America, and the Middle East & Africa).

Last Updated: || Author: Akshay Reddy || Reviewed: Akshay Reddy || SKU: MDP9829

Buy any syndicated report and get free complimentary customization of up to 20% of the Report and an interactive dashboard.

Report Summary
Table of Contents
List of Tables & Figures

Market Size 2033

US$1.83 billion

CAGR (2026-2033)

4.8%

Dominating Segment

Primary IV Tubing Sets

Fastest Growing

Asia-Pacific

IV Tubing Sets and Accessories Market Size and Trends

The global IV tubing sets and accessories market is estimated to reach US$1.38 billion in 2026 and US$1.83 billion by 2033, growing at a 4.8% CAGR during 2026–2033.

The rapid innovation in healthcare delivery is transforming patient care by enabling safer, more efficient drug administration and precise fluid management through advanced IV tubing sets and accessories. With their ability to ensure accurate dosing, maintain sterility, and minimize the risk of contamination, these devices are helping hospitals and clinics streamline workflows, reduce medication errors, and improve patient outcomes. This growing reliance on high-quality IV tubing solutions is enhancing operational efficiency, supporting critical care initiatives, and reinforcing overall healthcare safety, positioning IV tubing sets and accessories as an indispensable component of modern medical practice worldwide.

Global IV Tubing Sets and accessories Market size,2024-2033(USD Billion)||DataM Intelligence.com
Source : DataM Intelligence                                                                                                                             Email : [email protected]

IV Tubing Sets and Accessories Market Key Market highlights

  • North America dominates the market with over 41.2% revenue share, driven by the presence of high adoption of hospital automation systems, and strong government and private investments in critical care and infusion technologies.

  • Asia-Pacific is emerging as the fastest-growing region with a 17.9% share, supported by rising healthcare expenditures, expanding hospital networks, and increasing demand for efficient IV delivery systems in countries such as China and India.

  • The primary IV tubing sets segment dominates the market, accounting for 34.2% of the overall share, owing to the recurring need for sterile, reliable tubing in hospitals and clinics, which makes it a key revenue contributor in the global IV tubing sets and accessories sector.

IV Tubing Sets and Accessories Market Size & Forecast

  • 2026 Market Size:US$1.38 billion

  • 2033 Projected Market Size: US$1.83 billion

  • CAGR (2026–2033): 4.8%

  • North America: Largest market in 2024

  • Asia Pacific: Fastest-growing market

Drivers & Restraints

Driver: Rising prevalence of chronic diseases

The rising prevalence of chronic diseases is a major driver of the IV Tubing Sets and Accessories Market, as conditions such as cancer, diabetes, kidney disorders, and cardiovascular diseases often require continuous or long-term intravenous therapies for medication, nutrition, or fluid administration. According to the Centers for Disease Control and Prevention, six in 10 Americans have at least one chronic disease, and 4 in 10 have two or more chronic diseases. 

Patients undergoing chemotherapy, dialysis, or insulin infusions rely heavily on IV tubing sets for safe and accurate drug delivery, while the management of comorbidities in aging populations further amplifies demand. This surge in chronic illnesses not only increases hospital admissions but also fuels the adoption of home infusion therapies, where user-friendly and sterile IV tubing accessories play a critical role in reducing infection risks and improving patient outcomes.

Restraint: Stringent regulatory requirements

Stringent regulatory requirements can hamper the IV Tubing Sets and Accessories Market by increasing the time, cost, and complexity of bringing new products to market. Regulatory bodies such as the FDA (U.S.), EMA (Europe), and other national agencies enforce rigorous standards for product safety, sterility, biocompatibility, and material compliance, often requiring extensive testing and documentation. For instance, manufacturers must meet ISO standards for medical devices and demonstrate compliance with Good Manufacturing Practices (GMP), which can significantly lengthen approval timelines. Smaller companies, in particular, face challenges in managing the high costs of regulatory submissions, audits, and quality certifications. Moreover, frequent updates to guidelines on single-use plastics, infection control, and material safety can lead to redesigns or recalls, disrupting supply chains. While these regulations are essential for patient safety, they can limit innovation speed and restrict the entry of new players, thereby slowing overall market growth.

For more details on this report -  Request for Sample

IV Tubing Sets and Accessories Market Segmentation Analysis

The global IV tubing sets and accessories market is segmented by product type, application, end-user, and region.

Product Type: The primary IV tubing segment is estimated to have 34.2% of the IV tubing sets and accessories market share.

Primary IV tubing sets hold the largest share in the IV tubing sets and accessories market, as they are the standard component for administering fluids, medications, blood, and nutrition directly to patients. Their widespread use across hospitals, clinics, and home care settings for both acute and chronic conditions makes them indispensable in everyday clinical practice. 

The rising global prevalence of chronic diseases such as cancer, diabetes, and kidney disorders further fuels the demand for primary IV tubing sets. Additionally, their frequent use in surgical procedures, emergency care, and intensive care units (ICUs) reinforces their dominance in the market..

The secondary IV tubing sets segment is estimated to have 19.7% of the IV tubing sets and accessories market share.

Secondary IV tubing sets are the fastest-growing segment, driven by their increasing adoption in combination therapies, chemotherapy, and situations requiring the sequential administration of multiple medications through a single IV line. The efficiency they offer by minimizing the need for multiple venipunctures enhances patient comfort and reduces infection risks. As the trend of polypharmacy rises, especially among elderly and cancer patients, secondary IV tubing sets are becoming more essential in treatment regimens. Growing hospital demand for streamlined, cost-effective, and safe drug administration solutions positions this segment for rapid growth in the coming years.

Global IV Tubing Sets and accessories Market share by product type,2024(%)||DataM Intelligence.com
Source : DataM Intelligence                                                                                                                             Email : [email protected]

Geographical Analysis

The North America IV tubing sets and accessories market was valued at 41.2%market share in 2024

North America holds a dominant position in the global IV tubing sets and accessories market, accounting for a significant revenue share due to its high adoption of modern infusion technologies and strong government and private investments in hospital and critical care systems. The United States, in particular, plays a key role in driving market growth, supported by well-established hospital networks, stringent regulatory standards, and widespread awareness of patient safety and infection control protocols. 

The presence of leading manufacturers and distributors of IV tubing solutions, coupled with continuous innovations such as anti-kink tubing, antimicrobial coatings, and integrated safety features, further strengthens the region’s market leadership. Additionally, growing emphasis on outpatient care, home healthcare services, and technological upgrades in infusion devices ensures sustained demand for high-quality IV tubing sets and accessories across North America.

The Europe IV Tubing Sets and Accessories Market was valued at 21.8% market share in 2024

Europe maintains a significant position in the IV tubing sets and accessories market, characterized by steady growth driven by advanced healthcare systems, high regulatory standards, and widespread use of infusion therapies across hospitals and clinics. Countries such as Germany, France, and the United Kingdom lead the market, supported by strong hospital infrastructure, an aging population with increasing healthcare needs, and high awareness of patient safety protocols. 

Technological innovations, including precision IV tubing sets, safety-engineered connectors, and integrated monitoring systems, are widely adopted, enhancing patient outcomes and reducing the risk of infections. While the market in Europe is mature compared to North America and Asia-Pacific, ongoing investments in hospital modernization, home healthcare expansion, and preventive care solutions continue to drive demand for IV tubing sets and accessories across the region.

The Asia-Pacific IV tubing sets and accessories market was valued at 17.9% market share in 2024

The Asia-Pacific region is emerging as the fastest-growing market for IV tubing sets and accessories, driven by the increasing hospital capacities and rising government healthcare spending in countries such as China, India, and Japan. The region is witnessing growing demand for safe and efficient infusion systems due to a rising patient population, increasing prevalence of chronic diseases, and growing adoption of advanced therapeutic procedures. 

Expansion of modern hospitals, investment in training and certification of healthcare professionals, and increasing awareness of infection control practices are accelerating market adoption. Additionally, multinational manufacturers are expanding their presence and forming partnerships with regional distributors, further fueling growth in the Asia-Pacific. The combination of rising healthcare access, technological adoption, and favorable demographics positions this region as a high-growth market in the coming years. 

Global IV Tubing Sets and accessories Market share by Region,2024(%)||DataM Intelligence.com
Source : DataM Intelligence                                                                                                                             Email : [email protected]

IV Tubing Sets and Accessories Market Competitive Landscape

The major players in the IV tubing sets and accessories market include B.Braun SE, ICU Medical, Inc., BD, CODAN Companies, and Polymer, among others.

B. Braun SE: B. Braun SE is a major player in the IV tubing sets and accessories space, known for combining safety, material innovation, and user‐friendly design in its product portfolio. Their offerings include IV administration sets, extension sets, stopcocks, needle‐less connectors, filters, and infusion accessories.

IV Tubing Sets and Accessories Market Recent Developments:

  • July 2026 – ICU Medical and Otsuka expand U.S. IV solutions manufacturing capacity
    ICU Medical and Otsuka announced an investment of more than US$500 million to construct a new 500,000-square-foot manufacturing facility and upgrade an existing 700,000-square-foot site in Austin, Texas. The expansion is focused on non-DEHP IV solutions manufacturing, strengthening domestic supply capacity for infusion products and supporting demand for compatible IV tubing sets and accessories.
  • June 2026 – Amsino expands its IV administration set portfolio
    Amsino International received FDA 510(k) clearance for its AMSafe Administration Set in May 2026. The single-use, latex-free and non-DEHP administration set incorporates tubing, drip chambers, back-check valves, needle-free Y-sites, clamps, filters and Luer locks, supporting gravity and infusion-pump applications across hospitals and other healthcare settings.
  • June 2026 – New infusion set receives FDA clearance
    The FDA cleared the iiSure Infusion Set from Deka Research and Development in June 2026, reflecting continued product development and regulatory activity in infusion sets and IV delivery components.
  • March 2026 – Baxter launches IV Verify Line Labeling System
    Baxter introduced the IV Verify Line Labeling System, an automated bedside labeling solution developed through an exclusive distribution agreement with Vigilant Software. The system is designed to standardize IV line labeling, streamline nursing workflows and reduce medication-administration errors, supporting the broader shift toward safer and more integrated IV therapy workflows.
  • February 2026 – Baxter expands IV administration and extension-set portfolio
    Baxter continued strengthening its infusion consumables portfolio, with its IV product range covering primary and secondary sets, specialty sets, blood sets, BURETROL sets and catheter extension sets. This broad portfolio supports applications across hospitals and different infusion-care requirements.
  • 2025–2026 – Increasing adoption of non-DEHP and specialty IV tubing configurations
    Manufacturers are expanding tubing options designed around medication compatibility and patient-specific requirements, including non-DEHP PVC, polyurethane, polyethylene, TPE and low-sorbing materials. BD's portfolio also includes microbore and macrobore configurations, needle-free access, blood sets, burette sets and anti-run-dry technologies for different clinical applications.
  • 2025 – Baxter receives FDA clearance for solution administration sets
    Baxter's Solution Administration Sets received FDA 510(k) clearance in March 2025. The sets incorporate tubing, drip chambers, clamps, injection sites, filters, Luer connectors, stopcocks and manifolds, highlighting continued innovation across integrated IV tubing and accessory configurations.
  • 2025 – Growing regulatory activity across IV tubing and accessory products
    FDA records show multiple recent clearances covering administration sets, extension sets, needle-free connectors and infusion pump administration sets, including products from Baxter, BD, ICU Medical and other manufacturers. This reflects ongoing development of safer, compatible and application-specific IV consumables. 

IV Tubing Sets and Accessories Market Scope

Metrics

Details

CAGR

4.8%

Market Size Available for Years

2026-2033

Estimation Forecast Period

2025-2033

Revenue Units

Value (US $Bn) 

Segments Covered

Product Type

Primary IV Tubing Sets, Secondary IV Tubing Sets, Extension IV Tubing Sets, IV Tubing Accessories, Others

Application

Hydration, Blood Transfusions, Medication Delivery, Nutritional Support

End-User

Hospitals, Clinics, Ambulatory Surgery Centers, Others

Regions Covered

North America, Europe, Asia-Pacific, South America, and the Middle East & Africa

The global IV tubing sets and accessories market report delivers a detailed analysis with 70 key tables, more than 66 visually impactful figures, and 195 pages of expert insights, providing a complete view of the market landscape.

Suggestions for Related Report

For more medical disposables-related reports, please click here

Save 31% on all licenses
Single User$4350$2999Corporate$7850$5412

Free 20% customization + dashboard

Trusted by Global Leaders

ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
FAQ’s

  • The global IV tubing sets and accessories market is estimated to reach US$1.38 billion in 2026 and US$1.83 billion by 2033, growing at a 4.8% CAGR during 2026–2033.

  • Primary IV tubing sets lead the market with a 34.2% share due to their essential role in hospitals and clinics.

  • North America dominates with 41.2% share in 2024, while Asia-Pacific is the fastest-growing region.

  • Rising prevalence of chronic diseases, increasing hospital admissions, and adoption of home infusion therapies are driving growth.

  • Key players include B. Braun SE, ICU Medical Inc., BD, CODAN Companies, and Polymer.

  • Demand is increasing because IV tubing sets are widely used for controlled administration of medications, fluids, blood, and nutrition. The growing burden of chronic diseases and increasing use of infusion therapies are further supporting demand.

  • Asia-Pacific is the fastest-growing region in the IV Tubing Sets and Accessories Market. Rising healthcare expenditure, expanding hospital infrastructure, increasing patient populations, and greater adoption of efficient IV delivery systems are supporting regional growth.

  • The major end users are hospitals, clinics, and ambulatory surgery centers, along with other healthcare facilities. Hospitals represent a particularly important demand center because of their extensive use of IV therapies across emergency, surgical, intensive-care, and general treatment settings.

  • A major challenge is stringent regulatory requirements related to medical-device safety, sterility, biocompatibility, material compliance, and manufacturing quality. These requirements can increase product-development costs and extend approval timelines.

  • The market is expected to maintain steady growth through 2033 as healthcare providers increasingly prioritize safe medication delivery, infection control, accurate fluid administration, and efficient infusion systems. Expansion of healthcare infrastructure in emerging markets, particularly Asia-Pacific, is expected to create additional opportunities.
What Our Clients Say About this Report
Dr. Michael Anderson
Vice President, United States
11 Apr, 2026
5/5
The IV Tubing Sets and Accessories Market report gave our team a much clearer view of product demand, competitive positioning, and regional opportunities. The segmentation around primary and secondary IV tubing sets was particularly useful for our strategic planning. DataM Intelligence has done a good job of presenting complex market information in a practical format.
James Wilson
Chief Strategy Officer, United Kingdom
22 May, 2026
5/5
The IV tubing sets and accessories market analysis provided valuable perspective on the changing requirements of hospitals and infusion-care providers. I found the regional analysis particularly relevant for understanding where future demand could be strongest. It is a useful reference for strategic decision-making.
PDF
DataM
Global IV Tubing Sets and Accessories Market Report
SKU: MDP9829

Data-Backed Decisions Start Here

Explore how our research empowers industry leaders to cut through uncertainty. Get a free sample of this report or tailor it precisely to your business needs.

ISO 27001 Certified
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
ADM
Africa Climate Ventures
Algalif
Amcor
Arysta
Asahi
BASF
Baycurrent
BAYER
BioCartis
BIORAD
BRAUN
Budenheim
Daikin
Deerland
DENSO
DUPONT
Epax
FrieslandCampina
FUJIFILM
Hitachi
HONDA
HUAWEI
Inorganic Ventures
ITOCHU
JFE Steel
KAMEDA
Kaneka
KERRY
Marubeni
Meiji
Mitsubishi
MITSUI & Co
Morinaga
NFIT
NIPRO
Pfizer
Plexus
Polaris
Probiotical
RKW
Kearney
Takeda
Sensia
SACCO system
SEKISUI
SKYTILLER
Sony
Sumitomo Chemical
Symrise
Tate & Lyle
Teijin
thyssenkrupp
TORAY
TOSHIBA
Unilever
Xerox
Related Reports